OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder

Sievert, K-D; Chapple, C.; Herschorn, S.; Joshi, M.; Zhou, J.; Nardo, C.; Nitti, V. W.

dc.contributor.author	Sievert, Karl-Dietrich
dc.date.accessioned	2015-02-19T12:37:07Z
dc.date.available	2015-02-19T12:37:07Z
dc.date.issued	2014
dc.identifier.issn	1368-5031
dc.identifier.uri	http://hdl.handle.net/10900/59498
dc.language.iso	en	de_DE
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/ijcp.12443	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150115224006_00687	de_DE
utue.publikation.seiten	1246-1256	de_DE
utue.personen.roh	Sievert, K-D
utue.personen.roh	Chapple, C.
utue.personen.roh	Herschorn, S.
utue.personen.roh	Joshi, M.
utue.personen.roh	Zhou, J.
utue.personen.roh	Nardo, C.
utue.personen.roh	Nitti, V. W.
dcterms.isPartOf.ZSTitelID	International Journal of Clinical Practice	de_DE
dcterms.isPartOf.ZS-Issue	10	de_DE
dcterms.isPartOf.ZS-Volume	68	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE